BioXcel Therapeutics
BTAI
#9823
Rank
C$23.73 M
Marketcap
$0.49
Share price
8.12%
Change (1 day)
-87.78%
Change (1 year)

BioXcel Therapeutics (BTAI) - Cash on Hand

Cash on Hand as of September 2024 : C$58.14 Million

According to BioXcel Therapeutics's latest financial reports the company has C$58.14 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BioXcel Therapeutics - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31C$0.26 B-11.46%
2021-12-31C$0.29 B9.26%
2020-12-31C$0.27 B541.65%
2019-12-31C$42.35 M-26.96%
2018-12-31C$57.98 M5099.34%
2017-12-31C$1.11 M
2016-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$0.39 B 574.40%๐Ÿ‡บ๐Ÿ‡ธ USA